Nnamdi Gwacham, DO

Nnamdi Gwacham , DO

Physician

Cancer

Overview

Articles

Rapid recurrence of stage IIB non-gestational ovarian choriocarcinoma with minor yolk sac tumor: A rare case report and literature review

GYNECOLOGIC ONCOLOGY REPORTS

2023

Clinical outcomes analysis of neoadjuvant chemotherapy for locally advanced vulvar cancer

Gynecologic oncology

2023

Analysis of "sandwich" chemo-radiation therapy for stage IIIC endometrial cancer

Gynecologic oncology

2023

Malignant peritoneal cytologic contamination with robotic hysterectomy for endometrial cancer

Gynecologic oncology

2023

MALIGNANT PERITONEAL CYTOLOGIC CONTAMINATION WITH ROBOTIC HYSTERECTOMY FOR ENDOMETRIAL CANCER

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

2022

Multidisciplinary approach to pelvic leiomyomatosis with intracaval and intracardiac extension: A case report and review of the literature

GYNECOLOGIC ONCOLOGY REPORTS

2022

Neoadjuvant chemotherapy followed by fertility sparing surgery in cervical cancers size 2-4 cm; emerging data and future perspectives

Gynecologic oncology

2021

Isolated vulvar Langerhans cell histiocytosis

GYNECOLOGIC ONCOLOGY REPORTS

2021

Plexiform Neurofibroma of the Uterus: A Case Report

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

2021

Improved Outcomes With an Enhanced Recovery Approach to Cesarean Delivery

OBSTETRICS AND GYNECOLOGY

2020

More Publication Information

Associated Clinical Trials

NCT03517332

Association of ctDNA and circulating tumor cells after neoadjuvant chemotherapy with disease recurrence in patients with advanced stage epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.

Icon for trial | ctDNA Association of ctDNA and circulating tumor cells after neoadjuvant chemotherapy with disease recurrence in patients with advanced stage epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.

To compare the levels of ctDNA and CTCs using the SIGNATERA™ test in the peripheral blood of patients during neoadjuvant chemotherapy and after IDS for advanced stage epithelial ovarian carcinoma. Blood samples will be collecte ...